Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultraviolet Rays | 49 | 2015 | 575 | 3.190 |
Why?
|
| Dietary Fats | 18 | 2015 | 339 | 2.040 |
Why?
|
| Neoplasms, Radiation-Induced | 34 | 2010 | 388 | 2.020 |
Why?
|
| Antioxidants | 24 | 2015 | 507 | 1.910 |
Why?
|
| beta Carotene | 10 | 2010 | 76 | 1.430 |
Why?
|
| Fatty Acids, Omega-3 | 6 | 2020 | 83 | 1.150 |
Why?
|
| Anticarcinogenic Agents | 7 | 2010 | 362 | 1.140 |
Why?
|
| Skin Neoplasms | 33 | 2015 | 4654 | 1.010 |
Why?
|
| Ascorbic Acid | 7 | 2010 | 131 | 0.690 |
Why?
|
| Butylated Hydroxytoluene | 11 | 2004 | 13 | 0.680 |
Why?
|
| Hyperlipidemias | 1 | 2020 | 235 | 0.670 |
Why?
|
| Carotenoids | 5 | 2007 | 96 | 0.590 |
Why?
|
| Skin | 23 | 1996 | 1259 | 0.590 |
Why?
|
| Free Radicals | 8 | 2005 | 62 | 0.550 |
Why?
|
| Mice, Hairless | 20 | 2003 | 55 | 0.520 |
Why?
|
| Lipids | 5 | 2015 | 644 | 0.490 |
Why?
|
| Dietary Supplements | 6 | 2015 | 558 | 0.470 |
Why?
|
| Carcinogens | 8 | 2010 | 384 | 0.450 |
Why?
|
| Diet | 12 | 2015 | 1440 | 0.430 |
Why?
|
| Radiation-Protective Agents | 5 | 2004 | 128 | 0.430 |
Why?
|
| Tocopherols | 1 | 2010 | 19 | 0.380 |
Why?
|
| Lipid Peroxidation | 3 | 2006 | 157 | 0.360 |
Why?
|
| Vitamin E | 7 | 2004 | 136 | 0.350 |
Why?
|
| Fish Oils | 6 | 2020 | 88 | 0.330 |
Why?
|
| Sunlight | 3 | 1998 | 79 | 0.310 |
Why?
|
| Oxidants | 2 | 2004 | 49 | 0.310 |
Why?
|
| Diet, Fat-Restricted | 2 | 1998 | 56 | 0.300 |
Why?
|
| Cocarcinogenesis | 3 | 1995 | 50 | 0.270 |
Why?
|
| Animals | 58 | 2020 | 59536 | 0.260 |
Why?
|
| Fatty Acids, Unsaturated | 6 | 2006 | 94 | 0.260 |
Why?
|
| Epidermis | 6 | 2000 | 188 | 0.260 |
Why?
|
| Mice | 43 | 2020 | 34495 | 0.250 |
Why?
|
| Photosensitivity Disorders | 1 | 2004 | 23 | 0.250 |
Why?
|
| Reactive Oxygen Species | 3 | 2004 | 987 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2005 | 2359 | 0.230 |
Why?
|
| Cholesterol | 11 | 1980 | 658 | 0.220 |
Why?
|
| Trout | 1 | 2020 | 2 | 0.200 |
Why?
|
| Eels | 1 | 2020 | 3 | 0.200 |
Why?
|
| Ornithine Decarboxylase | 5 | 1994 | 31 | 0.190 |
Why?
|
| Neoplasms, Experimental | 10 | 1995 | 750 | 0.180 |
Why?
|
| Models, Chemical | 3 | 2006 | 186 | 0.170 |
Why?
|
| Haptens | 1 | 1998 | 15 | 0.170 |
Why?
|
| Light | 4 | 2006 | 245 | 0.150 |
Why?
|
| Antibody Formation | 1 | 1998 | 383 | 0.150 |
Why?
|
| Oxidation-Reduction | 5 | 2010 | 717 | 0.150 |
Why?
|
| Carcinogenicity Tests | 3 | 2003 | 70 | 0.140 |
Why?
|
| Keratosis | 2 | 1994 | 39 | 0.130 |
Why?
|
| Random Allocation | 3 | 2003 | 703 | 0.120 |
Why?
|
| Enzyme Induction | 5 | 1994 | 249 | 0.120 |
Why?
|
| Skin Aging | 1 | 1994 | 56 | 0.120 |
Why?
|
| Immune Tolerance | 1 | 1995 | 403 | 0.120 |
Why?
|
| PUVA Therapy | 2 | 1994 | 34 | 0.120 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1992 | 34 | 0.110 |
Why?
|
| Lipid Peroxides | 3 | 1987 | 22 | 0.110 |
Why?
|
| DNA | 3 | 1997 | 2693 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 1991 | 48 | 0.100 |
Why?
|
| Eicosanoids | 1 | 1991 | 31 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 1998 | 5437 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1994 | 272 | 0.100 |
Why?
|
| Glass | 1 | 1990 | 30 | 0.090 |
Why?
|
| Carcinoma | 2 | 2007 | 2578 | 0.090 |
Why?
|
| Plastics | 1 | 1990 | 93 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2005 | 1129 | 0.080 |
Why?
|
| Humans | 28 | 2015 | 261506 | 0.080 |
Why?
|
| Energy Intake | 2 | 2004 | 515 | 0.080 |
Why?
|
| Culture Media | 3 | 1990 | 319 | 0.080 |
Why?
|
| Lutein | 1 | 2007 | 15 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 1994 | 1058 | 0.070 |
Why?
|
| Sunscreening Agents | 1 | 1986 | 33 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 1990 | 5637 | 0.070 |
Why?
|
| Vegetables | 2 | 2001 | 325 | 0.070 |
Why?
|
| Neoplasms | 4 | 2004 | 15193 | 0.070 |
Why?
|
| Dinitrochlorobenzene | 1 | 1985 | 4 | 0.070 |
Why?
|
| Nitrobenzenes | 1 | 1985 | 30 | 0.070 |
Why?
|
| Phenols | 1 | 1986 | 107 | 0.070 |
Why?
|
| Female | 31 | 2003 | 141928 | 0.070 |
Why?
|
| Incidence | 3 | 2003 | 5673 | 0.070 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 1994 | 21 | 0.060 |
Why?
|
| Cell Survival | 2 | 1990 | 3045 | 0.060 |
Why?
|
| Singlet Oxygen | 2 | 2001 | 8 | 0.060 |
Why?
|
| Time Factors | 7 | 2007 | 12926 | 0.060 |
Why?
|
| Oils | 1 | 1983 | 9 | 0.060 |
Why?
|
| Smoking | 2 | 2004 | 2440 | 0.060 |
Why?
|
| Cholesterol, Dietary | 2 | 1997 | 54 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2004 | 553 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2004 | 255 | 0.050 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2004 | 164 | 0.050 |
Why?
|
| Epoxide Hydrolases | 2 | 1979 | 53 | 0.050 |
Why?
|
| Ethers, Cyclic | 3 | 1976 | 16 | 0.050 |
Why?
|
| Partial Pressure | 1 | 2001 | 39 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 566 | 0.050 |
Why?
|
| Carboxy-Lyases | 1 | 1980 | 13 | 0.050 |
Why?
|
| Corynebacterium | 1 | 1980 | 13 | 0.050 |
Why?
|
| Selenium | 1 | 2001 | 47 | 0.050 |
Why?
|
| 2-Acetylaminofluorene | 1 | 1980 | 11 | 0.050 |
Why?
|
| Sterilization | 1 | 1980 | 13 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2001 | 241 | 0.050 |
Why?
|
| Corn Oil | 3 | 1992 | 15 | 0.050 |
Why?
|
| Inflammation | 2 | 2006 | 2522 | 0.050 |
Why?
|
| Filtration | 1 | 1980 | 92 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 1375 | 0.050 |
Why?
|
| Interferons | 1 | 1981 | 291 | 0.040 |
Why?
|
| Radiation Effects | 6 | 1976 | 20 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 4938 | 0.040 |
Why?
|
| Mutagens | 1 | 1980 | 187 | 0.040 |
Why?
|
| Rats | 2 | 2007 | 6086 | 0.040 |
Why?
|
| Dinoprostone | 2 | 1991 | 208 | 0.040 |
Why?
|
| Epoxy Compounds | 2 | 1976 | 55 | 0.040 |
Why?
|
| Oxygen | 2 | 2001 | 754 | 0.040 |
Why?
|
| Picrates | 1 | 1998 | 3 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 931 | 0.040 |
Why?
|
| DNA Damage | 2 | 1997 | 1954 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 1991 | 3869 | 0.040 |
Why?
|
| Xanthophylls | 1 | 1998 | 5 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 5 | 1979 | 70 | 0.040 |
Why?
|
| Radiation Injuries, Experimental | 2 | 1978 | 82 | 0.040 |
Why?
|
| Sheep | 1 | 1998 | 258 | 0.040 |
Why?
|
| Rodentia | 1 | 1997 | 65 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 202 | 0.040 |
Why?
|
| Erythrocytes | 1 | 1998 | 339 | 0.040 |
Why?
|
| Edible Grain | 1 | 1997 | 54 | 0.040 |
Why?
|
| Methoxsalen | 1 | 1996 | 6 | 0.040 |
Why?
|
| DNA Adducts | 1 | 1997 | 210 | 0.040 |
Why?
|
| Food Additives | 1 | 1996 | 5 | 0.040 |
Why?
|
| Spectrophotometry | 2 | 1996 | 82 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 1998 | 446 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 1991 | 14289 | 0.030 |
Why?
|
| Mice, Nude | 5 | 1984 | 4307 | 0.030 |
Why?
|
| Hydro-Lyases | 1 | 1974 | 14 | 0.030 |
Why?
|
| Fatty Acids | 3 | 1993 | 448 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 3719 | 0.030 |
Why?
|
| Fruit | 1 | 1997 | 294 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 483 | 0.030 |
Why?
|
| Chromatography, Gas | 3 | 1985 | 39 | 0.030 |
Why?
|
| Disease Progression | 1 | 2005 | 6682 | 0.030 |
Why?
|
| Brevibacterium | 1 | 1993 | 1 | 0.030 |
Why?
|
| Piedra | 1 | 1993 | 1 | 0.030 |
Why?
|
| Trichosporon | 1 | 1993 | 16 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2007 | 7226 | 0.030 |
Why?
|
| Mitotic Index | 1 | 1994 | 162 | 0.030 |
Why?
|
| Hair | 1 | 1993 | 42 | 0.030 |
Why?
|
| Atrophy | 1 | 1994 | 261 | 0.030 |
Why?
|
| Point Mutation | 1 | 1996 | 769 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1997 | 1064 | 0.030 |
Why?
|
| Risk Factors | 2 | 2004 | 17523 | 0.030 |
Why?
|
| Photochemistry | 4 | 1980 | 39 | 0.030 |
Why?
|
| Mutagenicity Tests | 2 | 1985 | 69 | 0.030 |
Why?
|
| Sterols | 4 | 1974 | 23 | 0.030 |
Why?
|
| DNA Repair | 2 | 1997 | 1872 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1994 | 756 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 1992 | 43 | 0.030 |
Why?
|
| Erythema | 1 | 1992 | 52 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1996 | 1090 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 1991 | 36 | 0.030 |
Why?
|
| Carbon Isotopes | 4 | 1973 | 333 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2001 | 6100 | 0.020 |
Why?
|
| Glutathione | 4 | 1978 | 368 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 2594 | 0.020 |
Why?
|
| Luminescence | 1 | 1990 | 44 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1994 | 889 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 5767 | 0.020 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 1989 | 15 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 1977 | 726 | 0.020 |
Why?
|
| RNA | 1 | 1994 | 1013 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1994 | 2316 | 0.020 |
Why?
|
| Acetates | 3 | 1974 | 105 | 0.020 |
Why?
|
| Phospholipids | 3 | 1974 | 177 | 0.020 |
Why?
|
| Psoriasis | 1 | 1988 | 126 | 0.020 |
Why?
|
| Citrus paradisi | 1 | 2007 | 1 | 0.020 |
Why?
|
| Liver | 3 | 1986 | 2961 | 0.020 |
Why?
|
| Logistic Models | 1 | 1994 | 3441 | 0.020 |
Why?
|
| Prognosis | 1 | 2004 | 21713 | 0.020 |
Why?
|
| Middle Aged | 5 | 1997 | 86204 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2001 | 12873 | 0.020 |
Why?
|
| Aging | 1 | 1994 | 1582 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 548 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1985 | 95 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 1985 | 70 | 0.020 |
Why?
|
| Chemistry | 1 | 1984 | 99 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1984 | 137 | 0.020 |
Why?
|
| Toluene | 2 | 1974 | 13 | 0.020 |
Why?
|
| Photolysis | 2 | 1973 | 14 | 0.010 |
Why?
|
| Melanoma | 1 | 2001 | 5317 | 0.010 |
Why?
|
| Coenzyme A | 2 | 1973 | 11 | 0.010 |
Why?
|
| Mevalonic Acid | 2 | 1973 | 34 | 0.010 |
Why?
|
| Male | 7 | 2007 | 123000 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 5114 | 0.010 |
Why?
|
| Carbonates | 1 | 1980 | 12 | 0.010 |
Why?
|
| Body Weight | 1 | 1985 | 1293 | 0.010 |
Why?
|
| Esters | 1 | 1980 | 45 | 0.010 |
Why?
|
| Cellulose | 1 | 1980 | 22 | 0.010 |
Why?
|
| Biotransformation | 1 | 1980 | 93 | 0.010 |
Why?
|
| DNA Replication | 1 | 1984 | 744 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1980 | 115 | 0.010 |
Why?
|
| Cricetinae | 2 | 1980 | 706 | 0.010 |
Why?
|
| In Vitro Techniques | 2 | 1972 | 1618 | 0.010 |
Why?
|
| Radiochemistry | 1 | 1979 | 7 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 5395 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 14889 | 0.010 |
Why?
|
| Polymers | 1 | 1980 | 223 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1978 | 48 | 0.010 |
Why?
|
| Sunburn | 1 | 1978 | 35 | 0.010 |
Why?
|
| Disulfiram | 1 | 1978 | 38 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 37905 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 11538 | 0.010 |
Why?
|
| Mutation | 1 | 1997 | 15179 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1977 | 101 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 176 | 0.010 |
Why?
|
| Pulse Radiolysis | 1 | 1996 | 3 | 0.010 |
Why?
|
| Codon | 1 | 1996 | 241 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 153 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1996 | 148 | 0.010 |
Why?
|
| Lysosomes | 1 | 1977 | 347 | 0.010 |
Why?
|
| Glycerides | 1 | 1974 | 10 | 0.010 |
Why?
|
| Adult | 3 | 1997 | 77950 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1973 | 52 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 116 | 0.010 |
Why?
|
| Tellurium | 1 | 1993 | 8 | 0.010 |
Why?
|
| Base Composition | 1 | 1993 | 92 | 0.010 |
Why?
|
| Ribose | 1 | 1993 | 32 | 0.010 |
Why?
|
| Genitalia | 1 | 1993 | 46 | 0.010 |
Why?
|
| Cell Wall | 1 | 1993 | 46 | 0.010 |
Why?
|
| Butyrates | 1 | 1973 | 57 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1974 | 313 | 0.010 |
Why?
|
| Cholestanes | 1 | 1972 | 1 | 0.010 |
Why?
|
| Species Specificity | 1 | 1974 | 777 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1974 | 401 | 0.010 |
Why?
|
| Fats | 1 | 1971 | 16 | 0.010 |
Why?
|
| Xenon | 1 | 1971 | 19 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1971 | 132 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 558 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1993 | 414 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 3203 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 4233 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 4917 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 1988 | 20 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1972 | 483 | 0.010 |
Why?
|
| Swine | 1 | 1971 | 1541 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 3552 | 0.000 |
Why?
|
| Models, Biological | 1 | 1972 | 3254 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1993 | 2992 | 0.000 |
Why?
|
| Cricetulus | 1 | 1980 | 205 | 0.000 |
Why?
|
| Administration, Topical | 1 | 1978 | 257 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1980 | 741 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1978 | 1544 | 0.000 |
Why?
|